Financials

People

Activity

BioMedPartners

Company

Investment-firm

Financing round

General

About Company
BioMedPartners is a leading European venture capital firm.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

founders

Number of employees

IPO status

Private

Description

The Basel-based firm invests in early- and mid-stage healthcare and human life science companies with a focus on pharmaceuticals, biotechnology, diagnostics, and medical technology. They seek out companies with novel technologies or products that address important medical needs and have differentiated advantages over current treatment options. BioMedPartners targets Switzerland and surrounding EU countries, investing up to CHF 10 million over the lifetime of their portfolio companies. They often play a lead or co-lead investor role and syndicate with other venture capital firms.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Quaker BioVentures

Quaker BioVentures

Quaker BioVentures is a venture capital firm investing in life science companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Philadelphia, PA, USA

count Of Investments

43

count Of Exists

15
Pontifax

Pontifax

Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Herzliya, Israel

count Of Investments

97

count Of Exists

9
Vesalius Biocapital Partners

Vesalius Biocapital Partners

Vesalius Biocapital Partners is a European venture capital firm that invests in companies in the life sciences sector.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

Strassen, Luxembourg

count Of Investments

47

count Of Exists

6
Novartis Venture Fund

Novartis Venture Fund

Novartis Venture Fund is a private equity and venture capital arm of Novartis AG.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Basel, Switzerland

count Of Investments

201

count Of Exists

39

Financials

Investments
67
Date 
name 
Lead 
type 
Raised 
20.09.2023
Yes
$20.4M
16.09.2022
No
$46.95M
Local Amount - EUR 47M
07.06.2022
No
$72.92M
Local Amount - CHF 71M
TOLREMO therapeutics

TOLREMO therapeutics

TOLREMO therapeutics develops small molecules to target novel drug resistance pathways in cancer therapy.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Zürich, Switzerland

total rounds

4

total raised

$37.2M
Tricares

Tricares

TRiCares develops catheter-based valve replacement systems for minimally invasive treatment of tricuspid valve regurgitation.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Paris, France

total rounds

5

total raised

$77.83M
ImmunOs Therapeutics

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotech developing novel human immunomodulatory proteins for cancer and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

8952 Schlieren, Switzerland

total rounds

6

total raised

$90.79M
Co-Investors
Exits
12
CareX SA

CareX SA

CareX SA is a biopharmaceutical company focused on developing innovative treatments for metabolic and immune system disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

67400 Illkirch-Graffenstaden, France

total rounds

1

total raised

$32M
Amal Therapeutics

Amal Therapeutics

Amal Therapeutics develops therapeutic vaccines for oncology treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Geneva, Switzerland

total rounds

9

total raised

$45.34M
Okairos

Okairos

Okairos AG develops genetic T-cell vaccines for infectious diseases and cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Biotechnology, Health Care, Genetics

Location

Basel, Switzerland

total rounds

2

total raised

$30.08M

People

Founders
1
Gerhard Ries
Gerhard Ries

Gerhard Ries

Dr. Gerhard Ries is co-founder of BioMedInvest/BioMedCredit and has a strong background in the pharmaceutical, biotechnology and consulting industry. Previously, Dr. Ries was Partner at InterPharmaLink, a management consulting company, specializing on product portfolio- and supply chain optimization for large Pharma organizations. He has several years of working experience as project manager at McKinsey & Co. focusing on Pharma and Life Science companies. Dr. Ries was business development manager at Novartis responsible for licensing opportunities in the Biotech sector. Dr. Ries holds a M.S. and Ph.D. degree in Molecular Biology from the University of Basel and a diploma in Biotechnology from the Fachhochschule Weihenstephan. He has several years of research experience in the Pharma/Biotech sector gathered at Ciba Geigy, Boehringer Mannheim, Harvard Medical School and Max Planck-Institute for Biochemistry.

current job

kineo finance
kineo finance

Gerhard Ries

Employee Profiles
10
Stefan Fäs

Stefan Fäs

Chief Financial Officer & Partner

Gerhard Ries

Gerhard Ries

Co-Founder & General Partner

Andreas Wallnöfer

Andreas Wallnöfer

General Partner

Thomas Möller

Thomas Möller

General Partner

Helmut Fenner

Venture Partner

Fiona Lauscher

Fiona Lauscher

Office Manager

Patrick Burgermeister

Patrick Burgermeister

Partner

Valentin Piech

Valentin Piech

Venture Partner

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month